Department of Ophthalmology, Maisonneuve-Rosemont Hospital Research Center, Université de Montréal, 5415 Blvd de l'Assomption, Montréal, Québec, H1T 2M4, Canada.
Department of Pediatrics, Ophthalmology and Pharmacology, CHU Sainte-Justine Research Center, Université de Montréal, Montréal, QC, Canada.
J Neuroinflammation. 2017 Sep 6;14(1):181. doi: 10.1186/s12974-017-0955-x.
Tetrahydrobiopterin (BH4) is an essential cofactor in multiple metabolic processes and plays an essential role in maintaining the inflammatory and neurovascular homeostasis. In this study, we have investigated the deleterious effects of BH4 deficiency on retinal vasculature during development.
hph-1 mice, which display deficiency in BH4 synthesis, were used to characterize the inflammatory effects and the integrity of retinal microvasculature. BH4 levels in retinas from hph-1 and wild type (WT) mice were measured by LC-MS/MS. Retinal microvascular area and microglial cells number were quantified in hph-1 and WT mice at different ages. Retinal expression of pro-inflammatory, anti-angiogenic, and neuronal-derived factors was analyzed by qPCR. BH4 supplementation was evaluated in vitro, ex-vivo, and in vivo models.
Our findings demonstrated that BH4 levels in the retina from hph-1 mice were significantly lower by ~ 90% at all ages analyzed compared to WT mice. Juvenile hph-1 mice showed iris atrophy, persistent fetal vasculature, significant increase in the number of microglial cells (p < 0.01), as well as a marked degeneration of the retinal microvasculature. Retinal microvascular alterations in juvenile hph-1 mice were associated with a decreased expression in Norrin (0.2-fold) and its receptor Frizzled-4 (FZD4; 0.51-fold), as well as with an augmented expression of pro-inflammatory factors such as IL-6 (3.2-fold), NRLP-3 (4.4-fold), IL-1β (8.6-fold), and the anti-angiogenic factor thrombospondin-1 (TSP-1; 17.5-fold). We found that TSP-1 derived from activated microglial cells is a factor responsible of inducing microvascular degeneration, but BH4 supplementation markedly prevented hyperoxia-induced microglial activation in vitro and microvascular injury in an ex-vivo model of microvascular angiogenesis and an in vivo model of oxygen-induced retinopathy (OIR).
Our findings reveal that BH4 is a key cofactor in regulating the expression of inflammatory and anti-angiogenic factors that play an important function in the maintenance of retinal microvasculature.
四氢生物蝶呤(BH4)是多种代谢过程中的必需辅助因子,对维持炎症和神经血管内环境稳态起着至关重要的作用。在这项研究中,我们研究了 BH4 缺乏对发育过程中视网膜血管的有害影响。
利用 hph-1 小鼠,该小鼠缺乏 BH4 合成,以研究炎症作用和视网膜微血管完整性。采用 LC-MS/MS 测量 hph-1 和野生型(WT)小鼠视网膜中的 BH4 水平。在不同年龄时,量化 hph-1 和 WT 小鼠的视网膜微血管面积和小胶质细胞数量。通过 qPCR 分析视网膜中促炎、抗血管生成和神经元衍生因子的表达。在体外、离体和体内模型中评估 BH4 补充。
我们的研究结果表明,与 WT 小鼠相比,hph-1 小鼠视网膜中的 BH4 水平在所有分析的年龄都显著降低了约 90%。幼年 hph-1 小鼠表现出虹膜萎缩、持续性胎儿血管、小胶质细胞数量显著增加(p < 0.01),以及视网膜微血管明显退化。幼年 hph-1 小鼠的视网膜微血管改变与 Norrin(0.2 倍)及其受体 Frizzled-4(FZD4;0.51 倍)的表达减少以及促炎因子如 IL-6(3.2 倍)、NRLP-3(4.4 倍)、IL-1β(8.6 倍)和抗血管生成因子血小板反应蛋白-1(TSP-1;17.5 倍)的表达增加有关。我们发现,来源于活化小胶质细胞的 TSP-1 是诱导微血管退化的一个因素,但 BH4 补充显著预防了体外高氧诱导的小胶质细胞激活以及离体微血管血管生成模型和体内氧诱导的视网膜病变(OIR)模型中的微血管损伤。
我们的研究结果表明,BH4 是调节炎症和抗血管生成因子表达的关键辅助因子,这些因子在维持视网膜微血管方面起着重要作用。